Mouse Nerve Growth Factor Injection and Progression Rate in Patients With Amyotrophic Lateral Sclerosis: An Observational Study
ObjectivesAmyotrophic lateral sclerosis (ALS) is a progressive, fatal disease with no curative treatment up to now. This study aims to analyze ALS progression of patients treated with mouse nerve growth factor (mNGF), as well as the effects, side effects, and adverse events of the therapy.Materials...
Main Authors: | Jia-Tong Li, Si-Qi Dong, Ting Qian, Wen-Bo Yang, Xiang-Jun Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.829569/full |
Similar Items
-
Mountain Ginseng Pharmacopuncture Treatment on Three Amyotrophic Lateral Sclerosis Patients -Case Report-
by: Ryu Young-jin, et al.
Published: (2010-12-01) -
Accelerated Early Progression of Amyotrophic Lateral Sclerosis over the COVID-19 Pandemic
by: Fabiola De Marchi, et al.
Published: (2021-09-01) -
ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale
by: André Maier, et al.
Published: (2022-12-01) -
How COVID-19 pandemic changed our management strategies for amyotrophic lateral sclerosis (ALS) patients: Egyptian study
by: Hebatallah R. Rashed
Published: (2021-10-01) -
Eosinophils at diagnosis are elevated in amyotrophic lateral sclerosis
by: Jing Yang, et al.
Published: (2023-12-01)